The overarching goal of the project is to increase access to Medications for the treatment of Opiate Use Disorder (MOUD), coordinated and integrated care, and recovery support services to reduce the prevalence of OUDs, Stimulant Use Disorder, and stimulant/opioid related overdose deaths in the state of Arizona. The project approach includes developing and supporting state, regional and local level collaborations, substance use disorder (SUD) prevention programming, and service enhancements that enact evidence-based practices that comprehensively address the full continuum of care related to stimulant and opioid misuse, abuse, and dependence. The primary populations of focus for the Arizona State Opioid Response (SOR) grant are as follows: individuals with active opioid use; individuals with Opioid Use Disorder (OUD); individuals at risk for opioid overdose or misuse; individuals with stimulant use disorder; individuals in recovery; youth confronted with social pressures related to opioids/stimulants; and youth, parents, community members and health consumers unaware of the potential risks of opioid/stimulant misuse and abuse. Arizona has also identified the following sub-populations for targeted activities in SOR: individuals re-entering the community from correctional settings; individuals in rural and isolated areas; individuals without housing or with insecure housing; tribal populations; veterans, military service members and military families; pregnant women and parents with OUD, especially those with matters in family court or with Department of Child Safety involvement; individuals with physical disabilities; individuals needing pain management; and individuals who have experienced trauma, toxic stress or adverse childhood experiences (ACEs). Although funding will be used in part to address stimulant use, the bulk of focus remains on opioid misuse.
The project will serve 4,000,000 unduplicated individuals between year one and year two under prevention activities and serve 5,750 unduplicated individuals with treatment and recovery services in year one and an additional 6,500 unduplicated individuals in year two, for a total project reach of 12,250 unduplicated individuals. Of those individuals receiving treatment and recovery support services, 5,000 individuals will complete the CSAT GPRA Tool (2,200 intakes in year one and 2,800 in year two).